47 participants
SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-06
- Start Date:
- 2026-07-15
- Completion:
- 2029-07-15
Conditions
- Pancreatic Cancer
Interventions
- DRUG
No Results Yet